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Introduction
Bacterial vaginosis (BV), formerly called non-specific 
vaginitis, is a polymicrobial disease characterized by reduction 
in lactobacilli and hydrogen peroxide production, a rise in 
vaginal pH and  overgrowth of  BV associated organisms1. 
These BV associated pathogens are Gardnerella vaginalis, 
Ureaplasma urealyticum and anaerobes of  the genera 
Peptostreptococcus, Bacteroides, Mobiluncus, Prevotella, 
Fusobacterium, Veillonella and Eubacterium. 
BV affects 10.0% of  females2 and its prevalence varies from 
12.0 – 30.0%3-7. It is the commonest cause of  abnormal 
vaginal discharge in women of  childbearing age8 although 
majority of  cases are asymptomatic and remain unreported8.
BV is associated with an increased risk of  pelvic inflammatory 
disease, postoperative infections, cervicitis, HIV infection 
and probably cervical intraepithelial neoplasia1-4. Premature 
rupture of  membranes, preterm labour and delivery, 
chorioamnionitis and post-partum endometritis are some 
of  the obstetric complications1-8. Diagnostic tests for BV 
such as Amsel’s, Nugent’s or Spiegel’s criteria, gas-liquid 
chromatography with succinate:lactate ratio >4 and Fem 
Exam card test kit are available. BV has several adverse 
reproductive health outcomes and treatment of  the condition 
in women of  childbearing age will reduce these adverse 
outcomes. This study aimed at determining the prevalence 
and risk factors for BV among non-pregnant women of  
reproductive age in Ilorin, Nigeria and generate an otherwise 
dearth of  data for this group of  women. 
Methods 
The study was a cross-sectional study involving non-pregnant 
women aged 19 to 45 years attending the gynaecological 
clinic of  the University of  Ilorin Teaching Hospital, Ilorin 
Nigeria conducted between November, 2011 and March, 
2012. Consenting eligible participants were recruited and 
participated in the study. Pregnancy, menstruation, abnormal 
vaginal bleeding, urinary or faecal incontinence and 
antibiotics use within 72 hours prior to presentation were 
the exclusion criteria.
Using previously documented prevalence of  BV in non-
pregnant women of  14.0%6 and the Fisher’s formula9, the 
sample size of  212 participants including 10% attrition rate 
was calculated. The participants were selected by a systematic 
random sampling technique in which one out of  every two 
patients at the clinic who satisfied the inclusion criteria was 
recruited until the sample size was attained. An interviewer-
administered questionnaire purposely designed for the study 
was used to collect relevant information including socio-
demography, douching, smoking, contraception, sexual 
history, history of  previous preterm deliveries and sex with a 
high risk partner. A high-risk partner was defined as one who 
practices unprotected sex, has multiple sexual partners, has 
sex with a partner who has multiple other partners or has sex 
with intravenous drug users.
Vaginal swabs were collected by the researchers during 
speculum examination by passing sterile cotton wool swab 
into the fornix and gently rotated against the vaginal wall 
to obtain vaginal secretion specimens taking precaution to 
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avoid collecting cervical secretion. Swab specimens were 
placed inside Amines’s transport medium for transportation 
to the medical microbiology laboratory for processing.
 The vaginal swab was used for microscopy by making a thin 
smear on clean, dry and grease-free glass slides, air dried and 
gram stained. The stained slide was first examined under x40 
then x100 objective of  a compound light microscope. Three 
characteristic morphocytes i.e. Lactobacillus, Mobiluncus and 
Gardnerella, were sought during microscopic examination 
using their characteristics and scored appropriately using 
Nugent’s Criteria10.
All data was entered into the database and analysed using 
Statistical Package for Social Sciences (SPSS) version 20.0. 
Results were presented in tables.Categorical variables were 
described by proportions and comparison of  the study 
and control groups was done using chi-square or Yates 
corrected chi-square. Odds ratio and p<0.05 were termed 
significant.  Institutional ethical approval was obtained before 
commencement of  the study; participants were counselled 
and a written informed consent obtained at recruitment. 
Results
A total of  212 non-pregnant women of  reproductive age 
participated in the study, 85 were positive for BV giving a 
prevalence of  40.1%. It was commonest among the 25 to 
34 years age range (50; 58.8%). Nugent scoring showed that 
33(15.6%) had a score of  1-3, 94(44.3%) a score of  4-6 while 
85(40.1%) had a score of  7 or more. From table 1, the modal 
age group of  participants with BV was 30 to 34 years (28; 
32.9%), 77(90.6%) were married while 39(45.9%) had tertiary 
education. However, there was no statistical significance in the 
occurrence of  BV and the socio-demographic characteristics 
of  the participants. 
Table 1: Relationship between demographic characteristics and 
bacterial vaginosis







   < 20 1 (1.2) 0 (0) 0.049Y UD 0.826
   20-24 7 (8.2) 9 (7.1) 0.174 1.27 (0.383 – 4.390) 0.677
   25-29 22 (25.9) 40 (31.5) 0.037 0.92 (0.378 – 2.221) 0.847
   30-34 28 (32.9) 36 (28.3) 0.343 1.30 (0.543 – 3.093) 0.558
   35-39 15 (17.6) 22 (17.3) 0.067 1.14 (0.430 – 3.001) 0.796
    ≥ 40REF 12 (14.1) 20 (15.7)
Marital status
     Single 6 (7.1) 5 (3.9) 0.000Y 1.20 (0.059 – 24.473) 1.000
     Married 77 (90.6) 116 (91.3) 0.000Y 0.66 (0.041 – 10.773) 1.000
     Separated 1 (1.2) 5 (3.9) 0.000Y     0.20 (0.006 – 
6.664)
1.000
    Widowed REF 1 (1.2) 1 (0.8)
Education
      None 6 (7.1) 5 (3.9) 0.893 2.22 (0.6352 – 7.726) 0.345
      Primary 13 (15.3) 17 (13.4) 0.682 1.41 (0.621 – 3.207) 0.409
      Secondary 27 (31.8) 33 (26.0) 1.599 1.51 (0.796 – 2.867) 0.206
      Tertiary REF 39 (45.9) 72 (56.7)
X2: Chi square; Y: Yates corrected chi-square; UD: Undefined






   <18 10 (11.8) 18 (14.2) 0.258 0.81 (0.353 – 1.846) 0.612
   ≥18 75 (88.2) 109 (85.8)
Sexual partners
   0 1 (1.2) 1 (0.8) 0.000Y 1.00 (0.020 – 50.400) 1.000
   1 46 (54.1) 79 (62.2) 0.126Y     0.58 (0.036 – 9.533) 0.723
   2 31 (36.5) 40 (31.5) 0.296Y 0.78 (0.047 – 12.889) 0.586
   3 6 (7.1) 6 (4.7) 0.583Y 1.00 (0.050 – 19.964) 0.445
   4 1 (1.2) 1 (0.8)
 At risk partner 
   Yes 24 (28.2) 30 (23.6) 0.336 1.27 (0.565 – 2.857) 0.562
    No 44 (51.8) 70 (55.1) 0.000 0.99 (0.489 – 2.040) 0.996
   Don’t know 17 (20.0) 27 (21.3)
Vaginal douching
   Yes  36 (42.4) 60 (47.2) 0.492 0.82 (0.472 – 1.427) 0.483
   No  49 (57.6) 67 (52.8)
Douching 
frequency(n=96)
   1-10 4 (11.1) 8 (13.3) 0.015 0.75 (0.208 – 2.700) 0.901
   11-20 0 (0) 4 (6.7) 1.167Y 0.000 (UD) 0.280
   > 20 32 (88.9) 48 (80.0)
Previous discharge
   Yes 45 (52.9) 72 (56.7) 0.290 0.86 (0.495 – 1.492) 0.590
   No 40 (47.1) 55 (43.3)
Malodorous 
discharge
   Yes 16 (18.8) 21 (16.5) 0.185 1.17 (0.571 – 2.399) 0.667
   No 69 (81.2) 106 (83.5)
X2: Chi square; Y: Yates corrected chi-square; UD: Undefined
Table 2: Relationship between risk factors and occurrence of Bacterial 
Vaginosis





Family type (n =201)
   Monogamous 54 (69.2) 96 (78.1) 1.960 0.63 (0.333 – 1.204) 0.162
   Polygamous 24 (30.8) 27 (21.9)
Contraception 
   Yes 22 (25.9) 42 (33.1) 1.249 0.71 (0.384 – 1.301) 0.264
   No 63 (74.1) 85 (66.9)
Type of contraception
   IUD 15 (68.2) 24 (57.1) 0.739 1.61 (0.543 – 4.759) 0.390
   Other methods 7 (31.8) 18 (42.9)
Previous VTOP
   Yes 39 (45.9) 57 (44.9) 0.021 1.04 (0.600 – 1.808) 0.886
   No 46 (54.1) 70 (55.1)
Number (VTOP = 96)
   1 24 (61.5) 33 (57.9) 0.000Y 1.46 (0.125 – 16.981) 1.000
   2 11 (28.9) 18 (31.6) 0.221Y 1.22 
(0.099 – 15.114)
0.638
   3 3 (7.9) 4 (7.0) 0.179Y 1.50 
(0.089 – 25.393)
0.672
   4 1 (2.6) 2 (3.5)
Preterm delivery
    Yes 9 (10.6) 10 (7.9) 0.460 1.39 (0.538 – 3.567) 0.498
    No 76 (89.4) 117 (92.1)
χ2: Chi square; Y: Yates corrected chi-square;  UD: Undefined
Table 3: Relationship between family setting, contraception with previous 
http://dx.doi.org/10.4314/mmj.v29i4.2
Malawi Medical Journal 29 (3): September 2017 Bacterial vaginosis among non-pregnant women of reproductive age   292
number of  life time sexual partners, marriage type and male 
partner high-risk behaviour relative to acquisition of  BV in 
this study. However, some researchers reported a three-fold 
increase in probability for BV among women with multiple 
lifetime sexual partners18,19 while another study20 reported 
a lower prevalence of  BV in monogamous relationships. 
A probable explanation for this study report may be that 
participants may have been unaware of  the partners’ high-
risk sexual behaviour or unwilling to reveal them. The high 
rates of  BV have been shown to be associated with other 
reproductive tract infections (RTIs). A concurrence rate 
of  68% was reported for BV and other RTIs in a multi-
national study from Kenya, Rwanda and South Africa21 while 
a comparative study reported higher prevalence of  BV in 
HIV-positive women (46.0% vs. 20.5%, p<0.05) as well as 
higher prevalence for women with CD4 count <350cell/
mm3 (67% vs. 22%)22. A report from Malawi stated that 
the disturbance of  vaginal flora by BV predisposes to 
increased HIV acquisition in pregnancy with an odd of  
3.7 for antenatal and 2.3 for postnatal seroconversion23. If  
this association can be proved to be causal, it may explain 
the high prevalence of  HIV infection in African countries 
where BV rate is correspondingly high. However, this study 
is limited in this regard as its design did not provide for a 
concurrent evaluation for other RTIs in the participants.
A statistically significant link has been established between 
BV and sexual contact with new and multiple partners thereby 
emphasizing the need for safe sex practices24. The required 
protection is not limited to unwanted pregnancy but also 
includes the risk for other RTIs. This study demonstrated 
higher occurrence of  BV among IUD users corroborating 
a previous report of  alteration of  vagina flora in favour of  
the growth of  BV-associated organisms by IUD in-situ17.
However, progestin-only contraceptives were associated 
with lower likelihood of  BV in another study21. Therefore, 
women with higher risk for BV should consider barrier or 
hormonal contraceptives before IUD in order to reduce risk 
for infection. 
Although over 45.0% of  participants in this study practiced 
douching, it has no significant association with BV. Other 
researchers also reported that despite being a common 
risk factor, douching was not statistically significant for 
BV infection12,15. Another study showed that women who 
douched were 1.2 to 5.1 times more likely to develop BV 
than those who did not depending on the frequency of  
vaginal douching22. Nonetheless, the different reports on the 
association between BV and douching may be related to the 
contents or agents used for douching by different individuals 
which, apparently, were not investigated in these studies.
Previous history of  preterm delivery was found to be 
associated with BV occurrence in this study corroborating 
a previous report17. Therefore, women with prior history of  
preterm births should be screened for BV in early pregnancy 
and those found positive should be actively treated for 
the infection in the early second trimester to prevent a 
recurrence17.
The association between the frequency of  voluntary 
termination of  pregnancy (VTOP) and higher occurrence 
of  BV in this study corroborates a previous report which 
attributed this to the alteration of  vaginal flora in favour of  
the growth of  BV associated organisms18. This becomes 
important especially in countries with restrictive abortion 
laws where VTOP is synonymous with unsafe abortion.
From table 2, BV was associated with coitarche after 18 years 
(75; 88.2%), primiparity (46; 54.1%), douching frequency 
>20 (32; 88.9%) and previous vaginal discharge (45; 52.9%). 
However, none of  these was statistically significant. 
Table 3 shows that the use of  intrauterine device (IUD) (OR 
1.61, 95%CI 0.543-4.759; p0.020) and previous voluntary 
termination of  pregnancy (OR 1.04, 95%CI 0.600-1.808; 
p0.047) were statistically significant risk factors in BV. 
Multivariate analysis (table 4) showed that none of  the risk 
factors for BV was statistically significant in the development 
of  the infection. 
Discussion
This study reported a high prevalence rate of  40.1% for 
bacterial vaginosis (BV) among asymptomatic women 
of  reproductive age. The previously identified socio-
demographic, obstetric, gynaecological and social risk factors 
were identified among participants with BV in this study 
but only the use of  intrauterine contraception and previous 
unsafe abortion were statistically significant. This suggests 
that a universal approach combining both targeted and 
opportunistic screening of  women in the reproductive age at 
contacts with the health care provider could be explored to 
prevent the associated morbidity of  the infection. 
The high prevalence of  BV in this study compares to 20.0% 
to 49.0% from other African countries11-13. Although BV is 
reported as commoner in black compared to white women,13 
there is no clear explanation for the racial difference although 
we suggest that socioeconomic factors may be contributory. 
Socio-demographic characteristics were not significantly 
associated with BV in this study similar to the report of  
Baisley et al14. Another study which reported higher BV 
among younger women with low level of  formal education 
was not statistically significant15. However, Ness et al16 and 
Ashraf-Ganjoei17 both reported a significant association 
between low level of  education and BV. This may be because 
low social class has been associated with high risky sexual 
behaviours that may increase acquisition of  Reproductive 
Tract Infections (RTIs) including BV.16,17 In our study, 
majority of  women had tertiary education. This may be 
because our study is hospital-based where women of  higher 
educational level come more since they are more likely to be 
able to afford the cost of  care. This is a possible explanation 
for the different reports from different studies.
There was no statistical significant association between 
IUD: Intrauterine Device,VTOP: Voluntary Termination of 
Pregnancy
Table 4: Multivariate analysis of risk factors for bacterial vaginosis
Variable B p value OR (95% CI)
Coitarche -1.053 0.539 0.35 (0.012 – 10.066)
Sexual partners
   1 -21.816 1.000 0.00 (UD)
   2 -20.875 1.000 0.00 (UD)
   3 -41.953 0.999 0.00 (UD)
Malodorous vaginal 
discharge
-1.621 0.318 0.20 (0.008 – 4.759)
Family planning type -0.320 0.799 0.73 (0.062 – 8.521)
Number of VTOP -0.916 0.368 0.40 (0.054 – 2.939)
Preterm delivery 0.600 0.727 1.82 (0.063 – 52. 867)
UD: Undefined; VTOP: Voluntary Termination of Pregnancy.
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Strengths and limitations of the study
The strength of  this study is that it affords previously 
unavailable data on BV among non-pregnant women in 
North-Central Nigeria contributing to the pool of  available 
data on the infection in this group of  women. The design of  
the study as hospital-based is a limitation as women in the 
community who did not present at the health facility were 
excluded from the study. 
Conclusion
This study showed a high prevalence (40.1%) of  BV among 
non-pregnant asymptomatic women of  reproductive age 
attending a gynaecological clinic at University of  Ilorin 
Teaching Hospital, Ilorin, Nigeria. However, most of  the risk 
factors for BV were not statistically significant among the 
participants. Therefore, the study suggests that a universal 
approach combining targeted and opportunistic screening 
may be effective in preventing the attendant morbidities of  
BV among women.  
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